Daiichi Sankyo Co., Ltd.

This is the first time a new drug called DS-1062a is being tested in people. The main goal is to find a safe and tolerable dose for patients with advanced solid tumors, including lung and breast cancers, that have not responded to standard treatments. The study will also test if …

This study is testing whether the drug pexidartinib can shrink tumors and improve joint movement in adults with a rare, non-cancerous joint tumor called tenosynovial giant cell tumor (TGCT). The trial is for people whose condition causes severe pain or limits their movement and c…

This study is testing whether the drug pexidartinib is safe and effective for adults in Japan with a rare, non-cancerous joint tumor called tenosynovial giant cell tumor (TGCT). The trial is for people whose symptoms are severe and cannot be improved with surgery. Researchers wil…

This study continues testing an experimental treatment called DS-5141b for Duchenne muscular dystrophy. It follows 8 patients who completed an earlier trial to see if long-term use is safe and helps maintain muscle function. Researchers will measure walking ability, muscle streng…